Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Inflammatory Bowel Diseases

Free Subscription 13.01.2020 7 Aliment Pharmacol Ther 5 Am J Gastroenterol 1 BMC Gastroenterol 1 Dig Dis Sci 3 Dis Colon Rectum 1 Eur J Gastroenterol Hepatol 6 Gastroenterology 1 Gut 1 Hum Pathol 17 Inflamm Bowel Dis 12 J Crohns Colitis 1 J Gastroenterol 1 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Aliment Pharmacol Ther

1. LAI CY, Sung J, Cheng F, Tang W, et al
   Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation.
   Aliment Pharmacol Ther. 2019;49:354-363.
   PubMed     Text format     Abstract available
   
   
2. PANES J, D'Haens GR, Higgins PDR, Mele L, et al
   Long-term safety and tolerability of oral tofacitinib in patients with Crohn's disease: results from a phase 2, open-label, 48-week extension study.
   Aliment Pharmacol Ther. 2019;49:265-276.
   PubMed     Text format     Abstract available
   
   
3. SHOUVAL DS, Ben-Horin S
   Editorial: biomarker predictors of non-response to TNFalpha antagonists-the quest continues.
   Aliment Pharmacol Ther. 2019;49:1089-1090.
   PubMed     Text format    
   
   
4. VERSTOCKT B, Vermeire S, Ferrante M, Breynaert C, et al
   Editorial: biomarker predictors of non-response to TNFalpha antagonists - the quest continues. Authors' reply.
   Aliment Pharmacol Ther. 2019;49:1091-1092.
   PubMed     Text format    
   
   
5. CHAN SSM
   Editorial: differences in sex-based incidence of inflammatory bowel diseases between Asia-Pacific and Western countries - are these due to differences in environment, access to healthcare, or pathophysiology?
   Aliment Pharmacol Ther. 2019;49:1098-1099.
   PubMed     Text format    
   
   
6. MURPHY B, O'Kane D, McCourt C
   Letter: paradoxical skin eruptions during anti-TNF-alpha treatment of Crohn's disease.
   Aliment Pharmacol Ther. 2019;49:1369-1370.
   PubMed     Text format    
   
   
7. TANDON P, Govardhanam V, Leung K, Maxwell C, et al
   Systematic review with meta-analysis: risk of adverse pregnancy-related outcomes in inflammatory bowel disease.
   Aliment Pharmacol Ther. 2020 Jan 7. doi: 10.1111/apt.15587.
   PubMed     Text format     Abstract available
   
   

   
   Am J Gastroenterol

8. RIBALDONE DG
   ACG Clinical Guideline on Crohn's Disease: A Point of View from Europe.
   Am J Gastroenterol. 2019;114:826.
   PubMed     Text format    
   
   
9. CHAPMAN BJ, Jones GB
   Underscoring the Biochemical Overlap Between Crohn's Disease and Depression.
   Am J Gastroenterol. 2019;114:827-828.
   PubMed     Text format    
   
   
10. LICHTENSTEIN GR, Loftus EV, Isaacs KL, Regueiro MD, et al
    Response to Ribaldone.
    Am J Gastroenterol. 2019;114:826-827.
    PubMed     Text format    
    
    
11. LICHTENSTEIN GR, Loftus EV, Isaacs KL, Regueiro MD, et al
    Response to Chapman and Jones.
    Am J Gastroenterol. 2019;114:828.
    PubMed     Text format    
    
    
12. TARGOWNIK LE, Kaplan GG, Witt J, Bernstein CN, et al
    Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis.
    Am J Gastroenterol. 2020;115:128-137.
    PubMed     Text format     Abstract available
    
    

    
    BMC Gastroenterol

13. YU Q, Xu L, Li L, Zhi M, et al
    Internet and WeChat used by patients with Crohn's disease in China: a multi-center questionnaire survey.
    BMC Gastroenterol. 2019;19:97.
    PubMed     Text format     Abstract available
    
    

    
    Dig Dis Sci

14. SATYAM VR, Li PH, Reich J, Qazi T, et al
    Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 2. pii: 10.1007/s10620-019-06016.
    PubMed     Text format     Abstract available
    
    

    
    Dis Colon Rectum

15. YASSIN NA, Foppa C, Clerico G, Carvello M, et al
    Laparoscopic Pouch Excision Combined With Intersphincteric Resection.
    Dis Colon Rectum. 2019;62:1403.
    PubMed     Text format    
    
    
16. LEEDS IL, DiBrito SR, Canner JK, Haut ER, et al
    Cost-Benefit Limitations of Extended, Outpatient Venous Thromboembolism Prophylaxis Following Surgery for Crohn's Disease.
    Dis Colon Rectum. 2019;62:1371-1380.
    PubMed     Text format     Abstract available
    
    
17. LIGHTNER AL, McKenna NP, Alsughayer A, Harmsen WS, et al
    Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles?
    Dis Colon Rectum. 2019;62:1352-1362.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Gastroenterol Hepatol

18. MANTAKA A, Tsoukali E, Fragkaki M, Karmiris K, et al
    The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2020 Jan 8. doi: 10.1097/MEG.0000000000001674.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

19. PARK SH, Park SH
    Simplified Magnetic Resonance Index of Activity for Crohn's Disease-Let's Try to Kick It Up a Notch.
    Gastroenterology. 2020;158:281-282.
    PubMed     Text format    
    
    
20. DEBOURDEAU A, Boivineau L, Iltache S
    The Little Beast That Pretended to Be a Severe Crohn's Disease.
    Gastroenterology. 2019;157:1483-1484.
    PubMed     Text format    
    
    
21. BITTAR JM, Burton K, Rahnama S
    Verrucous Plaques of the Buttocks, Perineum, and Umbilicus.
    Gastroenterology. 2019;157:1480-1482.
    PubMed     Text format    
    
    
22. HARRIS MS, Wichary J, Zadnik M, Reinisch W, et al
    Competition for Clinical Trials in Inflammatory Bowel Diseases.
    Gastroenterology. 2019;157:1457-1461.
    PubMed     Text format    
    
    
23. COOK L, Stahl M, Han X, Nazli A, et al
    Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Gastroenterology. 2019;157:1584-1598.
    PubMed     Text format     Abstract available
    
    
24. WILLIET N, Jardin S, Roblin X
    The Simplified Magnetic Resonance Index of Activity (MARIA) for Crohn's Disease Is Strongly Correlated With the MARIA and Clermont Score: An External Validation.
    Gastroenterology. 2020;158:282-283.
    PubMed     Text format    
    
    

    
    Gut

25. BOSSUYT P, Nakase H, Vermeire S, de Hertogh G, et al
    Automatic, computer-aided determination of endoscopic and histological inflammation in patients with mild to moderate ulcerative colitis based on red density.
    Gut. 2020 Jan 8. pii: gutjnl-2019-320056. doi: 10.1136/gutjnl-2019-320056.
    PubMed     Text format     Abstract available
    
    

    
    Hum Pathol

26. MILLER GC, Liu C, Bettington ML, Leggett B, et al
    Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease.
    Hum Pathol. 2020 Jan 6. pii: S0046-8177(19)30234.
    PubMed     Text format     Abstract available
    
    

    
    Inflamm Bowel Dis

27. BEN-SHACHAR S, Finezilber Y, Elad H, Rabinowitz K, et al
    Genotype-Serotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2019;25:336-344.
    PubMed     Text format     Abstract available
    
    
28. BITTON A, Vutcovici M, Lytvyak E, Kachan N, et al
    Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives.
    Inflamm Bowel Dis. 2019;25:403-409.
    PubMed     Text format     Abstract available
    
    
29. DURICOVA D, Sarter H, Savoye G, Leroyer A, et al
    Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn's Disease: A French Population-Based Study.
    Inflamm Bowel Dis. 2019;25:394-402.
    PubMed     Text format     Abstract available
    
    
30. XU Y, Yang L, An P, Zhou B, et al
    Meta-Analysis: The Influence of Preoperative Infliximab Use on Postoperative Complications of Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:261-269.
    PubMed     Text format     Abstract available
    
    
31. DEEPAK P, Fowler KJ, Fletcher JG, Bruining DH, et al
    Novel Imaging Approaches in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2019;25:248-260.
    PubMed     Text format     Abstract available
    
    
32. SHAFER LA, Walker JR, Restall G, Chhibba T, et al
    Association Between IBD Disability and Reduced Work Productivity (Presenteeism): A Population-Based Study in Manitoba, Canada.
    Inflamm Bowel Dis. 2019;25:352-359.
    PubMed     Text format     Abstract available
    
    
33. RIVERA ED, Coffey JC, Walsh D, Ehrenpreis ED, et al
    The Mesentery, Systemic Inflammation, and Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:226-234.
    PubMed     Text format     Abstract available
    
    
34. SCHIRBEL A, Rebert N, Sadler T, West G, et al
    Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy.
    Inflamm Bowel Dis. 2019;25:294-305.
    PubMed     Text format     Abstract available
    
    
35. SHEN W, Li Y, Zou Y, Cao L, et al
    Mesenteric Adipose Tissue Alterations in Crohn's Disease Are Associated With the Lymphatic System.
    Inflamm Bowel Dis. 2019;25:283-293.
    PubMed     Text format     Abstract available
    
    
36. WEIZMAN AV, Nguyen GC, Seow CH, Targownik L, et al
    Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness Methodology.
    Inflamm Bowel Dis. 2019;25:328-335.
    PubMed     Text format     Abstract available
    
    
37. PERRY C, Kapur N, Barrett TA
    DDP-4 as a Novel Biomarker for Inflammatory Bowel Disease: Is It Ready for Clinical Use?
    Inflamm Bowel Dis. 2020 Jan 8. pii: 5698302. doi: 10.1093.
    PubMed     Text format    
    
    
38. PINTO-LOPES P, Afonso J, Pinto-Lopes R, Rocha C, et al
    Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 8. pii: 5698249. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
39. ROOSENBOOM B, van Lochem EG, Smids C, Groenen MJM, et al
    Analysis of Intestinal T-Cell Subsets in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020;26:e13.
    PubMed     Text format    
    
    
40. MORAES L, Magnusson MK, Mavroudis G, Polster A, et al
    Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms.
    Inflamm Bowel Dis. 2020 Jan 4. pii: 5696669. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
41. YU A, Friedman S, Ananthakrishnan AN
    Incidence and Predictors of Flares in the Postpartum Year Among Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 2. pii: 5694104. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
42. SHMIDT E, Saha S, Sands BE
    Reply to Letter to the Editor of Dr. Lai and Colleagues.
    Inflamm Bowel Dis. 2019;25:e166.
    PubMed     Text format    
    
    
43. DOVROLIS N, Drygiannakis I, Filidou E, Kandilogiannakis L, et al
    Gut Microbial Signatures Underline Complicated Crohn's Disease but Vary Between Cohorts; An In Silico Approach.
    Inflamm Bowel Dis. 2019;25:217-225.
    PubMed     Text format     Abstract available
    
    

    
    J Crohns Colitis

44. HAIN E, Maggiori L, Orville M, Treton X, et al
    Diverting Stoma for Refractory Ano-perineal Crohn's Disease: Is It Really Useful in the Anti-TNF Era? A Multivariate Analysis in 74 Consecutive Patients.
    J Crohns Colitis. 2019;13:572-577.
    PubMed     Text format     Abstract available
    
    
45. KAKUTA Y, Kawai Y, Naito T, Hirano A, et al
    A Genome-wide Association Study Identifying RAP1A as a Novel Susceptibility Gene for Crohn's Disease in Japanese Individuals.
    J Crohns Colitis. 2019;13:648-658.
    PubMed     Text format     Abstract available
    
    
46. CORRALIZA AM, Ricart E, Lopez-Garcia A, Carme Masamunt M, et al
    Differences in Peripheral and Tissue Immune Cell Populations Following Haematopoietic Stem Cell Transplantation in Crohn's Disease Patients.
    J Crohns Colitis. 2019;13:634-647.
    PubMed     Text format     Abstract available
    
    
47. RIPOLLES T, Martinez-Perez MJ, Paredes JM, Vizuete J, et al
    The Role of Intravenous Contrast Agent in the Sonographic Assessment of Crohn's Disease Activity: Is Contrast Agent Injection Necessary?
    J Crohns Colitis. 2019;13:585-592.
    PubMed     Text format     Abstract available
    
    
48. OSTROWSKI J, Dabrowska M, Lazowska I, Paziewska A, et al
    Redefining the Practical Utility of Blood Transcriptome Biomarkers in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2019;13:626-633.
    PubMed     Text format     Abstract available
    
    
49. CHAVANNES M, Martinez-Vinson C, Hart L, Kaniki N, et al
    Management of Paediatric Patients With Medically Refractory Crohn's Disease Using Ustekinumab: A Multi-Centred Cohort Study.
    J Crohns Colitis. 2019;13:578-584.
    PubMed     Text format     Abstract available
    
    
50. MAO R, Chen YJ, Chen BL, Xie XH, et al
    Intra-Cavitary Contrast-Enhanced Ultrasound: A Novel Radiation-Free Method for Detecting Abscess-Associated Penetrating Disease in Crohn's Disease.
    J Crohns Colitis. 2019;13:593-599.
    PubMed     Text format     Abstract available
    
    
51. HARRIS RE, Curtis L, Hegde V, Garrick V, et al
    A decade of Varicella screening within a paediatric inflammatory bowel disease population.
    J Crohns Colitis. 2019 Dec 31. pii: 5691246. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
52. SCOTT FI, Luo M, Shah Y, Lasch K, et al
    Identification of the most cost effective position of vedolizumab among the available biologic drugs for the treatment of ulcerative colitis.
    J Crohns Colitis. 2020 Jan 4. pii: 5696657. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
53. LUKAS M, Malickova K, Kolar M, Bortlik M, et al
    Switching from originator adalimumab to the biosimilar SB5 in patients with inflammatory bowel disease: Short-term experience from a single tertiary clinical center.
    J Crohns Colitis. 2020 Jan 6. pii: 5697282. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
54. AUGER N, Cote-Daigneault J, Bilodeau-Bertrand M, Arbour L, et al
    Inflammatory bowel disease and risk of birth defects in offspring.
    J Crohns Colitis. 2020 Jan 7. pii: 5697329. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
55. HEDIN CRH, Vavricka SR, Stagg AJ, Schoepfer A, et al
    The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy.
    J Crohns Colitis. 2019;13:541-554.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol

56. SUGITANI Y, Nishida A, Inatomi O, Ohno M, et al
    Sodium absorption stimulator prostasin (PRSS8) has an anti-inflammatory effect via downregulation of TLR4 signaling in inflammatory bowel disease.
    J Gastroenterol. 2020 Jan 8. pii: 10.1007/s00535-019-01660.
    PubMed     Text format     Abstract available
    
    

    
    Scand J Gastroenterol

57. ARKTEG CB, Goll R, Gundersen MD, Anderssen E, et al
    Mucosal gene transcription of ulcerative colitis in endoscopic remission.
    Scand J Gastroenterol. 2020 Jan 9:1-9. doi: 10.1080/00365521.2019.1710245.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: